These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Protection of the small intestine from nonocclusive mesenteric ischemic injury due to cardiogenic shock. Bailey RW, Bulkley GB, Hamilton SR, Morris JB, Haglund UH. Am J Surg; 1987 Jan; 153(1):108-16. PubMed ID: 3799886 [Abstract] [Full Text] [Related]
6. Control of gastric vascular resistance in cardiogenic shock. Bulkley GB, Oshima A, Bailey RW, Horn SD. Surgery; 1985 Aug; 98(2):213-23. PubMed ID: 3895536 [Abstract] [Full Text] [Related]
7. Hemodynamics of pancreatic ischemia in cardiogenic shock in pigs. Reilly PM, Toung TJ, Miyachi M, Schiller HJ, Bulkley GB. Gastroenterology; 1997 Sep; 113(3):938-45. PubMed ID: 9287987 [Abstract] [Full Text] [Related]
10. The renin-angiotensin system in swine during hypovolaemic shock combined with low-flow ischaemia of the sigmoid colon. Yilmaz EN, Vahl AC, van Rij GL, Vink GQ, Lange-De Klerk ES, Brom HL, Rauwerda JA. Cardiovasc Surg; 1999 Aug; 7(5):539-44. PubMed ID: 10499897 [Abstract] [Full Text] [Related]
11. The effect of inhibition of renin-angiotensin system by valsartan during hypovolemic shock and low flow sigmoideal ischaemia in pigs. Yilmaz EN, Vahl AC, van Rij GL, Vink GQ, Brom HL, Rauwerda JA. Cardiovasc Surg; 2003 Feb; 11(1):45-51. PubMed ID: 12543572 [Abstract] [Full Text] [Related]
12. The mesenteric hemodynamic response to circulatory shock: an overview. Reilly PM, Wilkins KB, Fuh KC, Haglund U, Bulkley GB. Shock; 2001 May; 15(5):329-43. PubMed ID: 11336191 [Abstract] [Full Text] [Related]
17. Incidence and outcomes associated with early heart failure pharmacotherapy in patients with ongoing cardiogenic shock. van Diepen S, Reynolds HR, Stebbins A, Lopes RD, Džavík V, Ruzyllo W, Geppert A, Widimsky P, Ohman EM, Parrillo JE, Dauerman HL, Baran DA, Hochman JS, Alexander JH. Crit Care Med; 2014 Feb; 42(2):281-8. PubMed ID: 23982033 [Abstract] [Full Text] [Related]
18. Protective effect of agiotensin II type I receptor antagonist, CV-11974, on ischemia and reperfusion injury of the liver. Masuko H, Jin MB, Horiuchi H, Suzuki T, Taniguchi M, Shimamura T, Fukai M, Magata S, Ogata K, Ishikawa H, Fujita M, Nagashima K, Furukawa H, Todo S. Transplantation; 2001 Apr 27; 71(8):1034-9. PubMed ID: 11374397 [Abstract] [Full Text] [Related]
19. Major hepatic trauma: warm ischemic tolerance of the liver after hemorrhagic shock. Perdrizet GA, Giles DL, Dring R, Agarwal SK, Khwaja K, Gao YZ, Geary M, Cowell VL, Berman M, Brautigam R. J Surg Res; 2006 Nov 27; 136(1):70-7. PubMed ID: 17007881 [Abstract] [Full Text] [Related]
20. Hepatic arterial and portal flow in cardiogenic and hemorrhagic shock in awake dogs. Hirsch LJ, Rone AS. Circ Shock; 1982 Nov 27; 9(1):17-26. PubMed ID: 6279331 [Abstract] [Full Text] [Related] Page: [Next] [New Search]